AmerisourceBergen Escapes Investor Drug-Dregs Suit In Del.
Delaware's Court of Chancery on Friday tossed shareholder claims that AmerisourceBergen Corp. directors failed to curtail a division's illegal repackaging of cancer drugs, finding a single independent board member's investigation into...To view the full article, register now.
Already a subscriber? Click here to view full article